178 related articles for article (PubMed ID: 15857753)
1. Inhibition of the 26S proteasome blocks progesterone receptor-dependent transcription through failed recruitment of RNA polymerase II.
Dennis AP; Lonard DM; Nawaz Z; O'Malley BW
J Steroid Biochem Mol Biol; 2005 Mar; 94(4):337-46. PubMed ID: 15857753
[TBL] [Abstract][Full Text] [Related]
2. Dynamic histone acetylation/deacetylation with progesterone receptor-mediated transcription.
Aoyagi S; Archer TK
Mol Endocrinol; 2007 Apr; 21(4):843-56. PubMed ID: 17227884
[TBL] [Abstract][Full Text] [Related]
3. Proteasome activity modulates chromatin modifications and RNA polymerase II phosphorylation to enhance glucocorticoid receptor-mediated transcription.
Kinyamu HK; Archer TK
Mol Cell Biol; 2007 Jul; 27(13):4891-904. PubMed ID: 17438138
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of glucocorticoid signaling through targeted degradation of p300 via the 26S proteasome pathway.
Li Q; Su A; Chen J; Lefebvre YA; Haché RJ
Mol Endocrinol; 2002 Dec; 16(12):2819-27. PubMed ID: 12456802
[TBL] [Abstract][Full Text] [Related]
5. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor.
Wagner BL; Norris JD; Knotts TA; Weigel NL; McDonnell DP
Mol Cell Biol; 1998 Mar; 18(3):1369-78. PubMed ID: 9488452
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the content of progesterone and estrogen receptors, and their cofactors SRC-1 and SMRT by the 26S proteasome in the rat brain during the estrous cycle.
Villamar-Cruz O; Manjarrez-Marmolejo J; Alvarado R; Camacho-Arroyo I
Brain Res Bull; 2006 Apr; 69(3):276-81. PubMed ID: 16564422
[TBL] [Abstract][Full Text] [Related]
7. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
[TBL] [Abstract][Full Text] [Related]
8. Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity.
Narayanan R; Edwards DP; Weigel NL
Mol Cell Biol; 2005 Apr; 25(8):2885-98. PubMed ID: 15798179
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the SMRT/NCoR-HDAC3 complex in transcriptional repression by the CNOT2 subunit of the human Ccr4-Not complex.
Jayne S; Zwartjes CG; van Schaik FM; Timmers HT
Biochem J; 2006 Sep; 398(3):461-7. PubMed ID: 16712523
[TBL] [Abstract][Full Text] [Related]
10. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking.
Deroo BJ; Rentsch C; Sampath S; Young J; DeFranco DB; Archer TK
Mol Cell Biol; 2002 Jun; 22(12):4113-23. PubMed ID: 12024025
[TBL] [Abstract][Full Text] [Related]
11. Contribution of HDAC3 to transcriptional repression by the human papillomavirus 31 E8^E2 protein.
Dreer M; Blondzik S; Straub E; Iftner T; Stubenrauch F
J Gen Virol; 2020 Jul; 101(7):751-759. PubMed ID: 32421493
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.
De Amicis F; Zupo S; Panno ML; Malivindi R; Giordano F; Barone I; Mauro L; Fuqua SA; Andò S
Mol Endocrinol; 2009 Apr; 23(4):454-65. PubMed ID: 19147702
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibition creates a chromatin landscape favorable to RNA Pol II processivity.
Kinyamu HK; Bennett BD; Bushel PR; Archer TK
J Biol Chem; 2020 Jan; 295(5):1271-1287. PubMed ID: 31806706
[TBL] [Abstract][Full Text] [Related]
14. TBLR1 regulates the expression of nuclear hormone receptor co-repressors.
Zhang XM; Chang Q; Zeng L; Gu J; Brown S; Basch RS
BMC Cell Biol; 2006 Aug; 7():31. PubMed ID: 16893456
[TBL] [Abstract][Full Text] [Related]
15. Interaction of NCOR/SMRT Repressor Complexes with Papillomavirus E8^E2C Proteins Inhibits Viral Replication.
Dreer M; Fertey J; van de Poel S; Straub E; Madlung J; Macek B; Iftner T; Stubenrauch F
PLoS Pathog; 2016 Apr; 12(4):e1005556. PubMed ID: 27064408
[TBL] [Abstract][Full Text] [Related]
16. Progesterone induction of the 11beta-hydroxysteroid dehydrogenase type 2 promoter in breast cancer cells involves coordinated recruitment of STAT5A and progesterone receptor to a distal enhancer and polymerase tracking.
Subtil-Rodríguez A; Millán-Ariño L; Quiles I; Ballaré C; Beato M; Jordan A
Mol Cell Biol; 2008 Jun; 28(11):3830-49. PubMed ID: 18378698
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
[TBL] [Abstract][Full Text] [Related]
18. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
19. Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors.
Beck CA; Weigel NL; Edwards DP
Mol Endocrinol; 1992 Apr; 6(4):607-20. PubMed ID: 1316549
[TBL] [Abstract][Full Text] [Related]
20. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
